Table 1 Precursor molar ratios (silver nitrate/indium chloride/zinc stearate/DDT/sulfur in 1 mL of OLA) and characteristics of Ag–In–Zn–S nanocrystals: before and after ligand exchange for MUA, Cys, and LA. TEM was used for size studies
From: Quantum dots as targeted doxorubicin drug delivery nanosystems in human lung cancer cells
Ligand | Ag/In/Zn/SDDT/Ss | Ag/In/Zn/S | Sizea (nm) | PLb (nm) | Q.Y.c (%) |
|---|---|---|---|---|---|
Initial ligands* | 1.0/3.5/8.1/5.8/2.6 | 1.0/1.5/7.8/17.0 | 3.2 ± 0.4 | 543 | 48.0 |
MUA | 1.0/1.2/5.6/9.4 | 3.1 ± 0.6 | 576 | 25.0 | |
Initial ligands* | 1.0/3.5/8.1/5.8/2.6 | 1.0/1.5/7.8/17.0 | 3.2 ± 0.4 | 543 | 48.0 |
Cys | 1.0/6.8/14.3/154.2 | 3.1 ± 1.0 | 524 | 16.0 | |
Initial ligands* | 1.0/3.5/8.1/5.8/2.6 | 1.0/1.5/7.8/17.0 | 3.2 ± 0.4 | 543 | 48.0 |
LA | 1.0/1.0/8.8/25.1 | 3.0 ± 0.7 | 540 | 28.0 |